July, 2021 | Press release
ExThera Expands Distribution of Blood Purification and Pathogen Reduction Treatment for Sepsis and COVID-19 in Europe. ExThera Medical and Fresenius Medical Care to offer Seraph 100 Microbind Affinity Filter in Turkey, Finland, and Estonia

MARTINEZ, Calif. – ExThera Medical, maker of the only effective pathogen-removal, hemoperfusion filter approved for patient use in Europe, and Fresenius Medical Care, the world’s leading provider of products and...

Read more
July, 2021 | Press release
BioMedSA Announces ExThera’s CEO as the Winner of the 2021 Innovation Award in Healthcare and Bioscience

An inventor of a Groundbreaking Device to Treat COVID-19 and other bloodstream infections, ExThera Medical’s CEO Robert Ward to be Recognized by BioMedSA for Innovation in Healthcare and Bioscience ExThera...

Read more
June, 2021 | Publication
Heparin-based blood purification attenuates organ injury in baboons with S. pneumoniae pneumonia

Heparin-based blood purification attenuates organ injury in baboons with S. pneumoniae pneumonia. Download the full article here

Read more
June, 2021 | Press release
Clinical Trial for Groundbreaking Device to Treat Septic Shock set to Begin

MARTINEZ, Calif. – ExThera Medical’s Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100), a blood purification device with many potential applications including the treatment of sepsis, will be studied in...

Read more
June, 2021 | Publication
Hemofiltration with the Seraph®100 Microbind® Affinity filter decreases SARS-CoV-2 nucleocapsid protein in critically ill COVID-19 patients

Hemofiltration with the Seraph®100 Microbind® Affinity filter decreases SARS-CoV-2 nucleocapsid protein in critically ill COVID-19 patients Download the full article here

Read more
May, 2021 | Press release
Blood Purification and Pathogen Reduction Treatment for Sepsis and COVID-19 Set for Pan-European Distribution Launch

MARTINEZ, Calif. – ExThera Medical’s Seraph 100® Microbind® Affinity Filter (Seraph 100) is now being distributed in Europe by Fresenius Medical Care, the world’s leading provider of products and services...

Read more
May, 2021 | Press release
Vall d’Hebron Barcelona Hospital Campus begins two clinical trials to test a new system to filter blood and improve the evolution of COVID-19 and sepsis

Vall d’Hebron Barcelona Hospital Campus begins two clinical trials to test a new system to filter blood and improve the evolution of COVID-19 and sepsis Seraph 100 consists of a...

Read more
April, 2021 | Press release
Seraph 100 Blood Filter Shows Substantially Improved Survival Rates for COVID-19 Patients

MARTINEZ, Calif. – ExThera Medical announced today the release of preliminary clinical study data demonstrating significantly improved survival rates among critically ill COVID-19 patients when treated with the Seraph® 100...

Read more
April, 2021 | Publication
A Multicenter Evaluation of Blood Purification with Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19: A Preliminary Report

The Seraph®100 Microbind Affinity Blood Filter® (Seraph 100) is an extracorporeal medical countermeasure that can remove many pathogens from blood, including the SARS-CoV-2 virus. The aim of this study was...

Read more
April, 2021 | Publication
Treatment of a Critically Ill COVID-19 Patient with the Seraph 100 Microbind Affinity Filter

This case report suggests that the use of Seraph 100 Microbind Affinity filter hemoperfusionmight have positive effects on the clinical course of critically ill patients with COVID-19. Download the full...

Read more